FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02808481|
Recruitment Status : Unknown
Verified May 2016 by University Hospital, Strasbourg, France.
Recruitment status was: Not yet recruiting
First Posted : June 21, 2016
Last Update Posted : June 21, 2016
Systemic sclerosis is a rare disease. The early cardiac disease affects 10% of patients sclérodemiques.
Heart transplantation in the early cardiac involvement in systemic sclerosis is exceptional.
we see patient data analysis with systemic sclerosis who used cardiac transplantation to understand the primitive cardiac damage associated with systemic sclerosis
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||9 participants|
|Study Start Date :||June 2016|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
- Analysis of data from patients with systemic sclerosis who used cardiac transplantation for primary cardiac involvement [ Time Frame: 1month post-transplantation ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02808481
|Contact: Emmanuel CHATELUS, MD||33 (0)email@example.com|